Glasa Jozef
Slovak Postgraduate Academy of Medicine, Institute of Medical Ethics and Bioethics Foundation, Limbova 12, 833 03 Bratislave, Slovak Republic.
Med Etika Bioet. 2002 Spring-Summer;9(1-2):9-12.
The genuine reform efforts in medicine and health care in Central and East European (CEE) countries have continued to pose important and thought-provoking challenges to the newly reborn disciplines of medical ethics (or bioethics). They are embodied in the bulk of new ethical problems, concepts and quandaries brought about by the developments, changes, clashes, and "real life" issues of the CEE countries' health care systems and biomedical sciences. Certain part, quite variable from country to country, of this bio-ethical endeavour has been confined to the work and activities of ethics committees (ECs) or similar bodies. They have emerged in varying number, shape, composition, competence, legal status, responsibility and time of appearance, in almost all transition countries of CEE. They may be considered as a kind of "field workplaces" of medical ethics/bioethics within the countries' HCSs or biomedical research structures. Despite some shortcomings and drawbacks, a lot has already been achieved. In some countries the progress has been quick and systematic. The major pitfalls were mostly due to the missing, weak or unclear legal backing of ECs' establishment and work; lack of education and training of their members; insufficient support from health care administrators; misconceptions concerning their mission, procedures, scope of responsibility, and reporting; insufficient or missing funding; low profile societal esteem for ECs' work; but some drawbacks were due also to the underdeveloped 'dialogic' culture of the impartial discussion and democratic discourse in the 'post-totalitarian' CEE transition countries. The future of ECs in CEE will be connected to the countries' integration and harmonization efforts towards research, health systems, and other international structures in Europe and beyond. This should need an extensive and non-discriminatory international partnership, exchange and co-operation.
中东欧(CEE)国家在医疗卫生领域的真正改革努力,继续给新生的医学伦理学(或生物伦理学)学科带来重要且发人深省的挑战。这些挑战体现在中东欧国家医疗保健系统和生物医学科学的发展、变化、冲突及“现实生活”问题所引发的大量新伦理问题、概念和困境之中。在这一生物伦理努力中,因国家而异的一定部分工作局限于伦理委员会(ECs)或类似机构的工作与活动。在中东欧几乎所有转型国家,它们以不同的数量、形式、组成、权限、法律地位、责任及出现时间涌现出来。它们可被视为各国医疗保健系统(HCSs)或生物医学研究结构中医学伦理学/生物伦理学的一种“实地工作场所”。尽管存在一些缺点和不足,但已经取得了很多成果。在一些国家,进展迅速且系统。主要问题大多源于伦理委员会的设立和工作缺乏、薄弱或不明确的法律支持;其成员缺乏教育和培训;医疗保健管理人员支持不足;对其使命、程序、责任范围和报告存在误解;资金不足或缺失;社会对伦理委员会工作的认可度低;但一些问题也归因于中东欧“后极权主义”转型国家公正讨论和民主话语的“对话”文化不发达。中东欧伦理委员会的未来将与各国在研究、卫生系统以及欧洲及其他地区的其他国际结构方面的整合与协调努力相关联。这需要广泛且无歧视的国际伙伴关系、交流与合作。